Contribution of glycosylated recombinant human granulocyte colony-stimulating factor (lenograstim) use in current cancer treatment: review of clinical data

Multicenter Randomized Open-Label Phase III Study Comparing Efficacy, Safety, and Tolerability of Conventional Carboplatin Plus Etoposide Versus Dose-Intensified Carboplatin Plus Etoposide Plus Lenograstim in Small-Cell Lung Cancer in “Extensive Disease” Stage

(2010) David Felix Heigener et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Mobilization of CD34+ cells by glycosylated and nonglycosylated G-CSF in healthy volunteers - a comparative study

(2010) M. Höglund et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors

(2009) K. Holig et al.   BLOOD

Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience

(2009) M Martino et al.   BONE MARROW TRANSPLANTATION

GM-CSF accelerates proliferation of endothelial progenitor cells from murine bone marrow mononuclear cells in vitro

(2009) Qi Ru Wang et al.   CYTOKINE

G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models

(2009) F. Shojaei et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: A randomized study in patients undergoing autologous peripheral stem cell transplantation

(2008) Selmin Ataergin et al.   AMERICAN JOURNAL OF HEMATOLOGY

Novel Strategies for Granulocyte Colony-Stimulating Factor Treatment of Severe Prolonged Neutropenia Suggested by Mathematical Modeling

(2008) E. Shochat et al.   CLINICAL CANCER RESEARCH

Effects and safety of granulocyte colony-stimulating factor in healthy volunteers

(2008) Paolo Anderlini   CURRENT OPINION IN HEMATOLOGY

Pegfilgrastim; a neutrophil mediated granulocyte colony stimulating factor–expanding uses in cancer chemotherapy

(2008) Mariko Morishita et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Treatment with granulocyte colony stimulating factor is associated with improvement in endothelial function

(2008) Ignatios Ikonomidis et al.   GROWTH FACTORS

Prospective randomized comparative observation of single- versus split-dose lenograstim to enhance engraftment after autologous stem cell transplantation in patients with multiple myeloma or non-Hodgkin's lymphoma

(2008) Geundoo Jang et al.   TRANSFUSION

Cost benefit and clinical efficacy of low-dose granulocyte colony-stimulating factor after standard chemotherapy in patients with non-Hodgkin's lymphoma

(2007) S. HASHINO et al.   International Journal of Laboratory Hematology